Identification of a mutation in TNRC18 in a patient with clinical features of Fazio‐Londe disease
Key Clinical Message Fazio‐Londe disease and Brown‐Vialetto‐Van Laere syndrome are rare related neurological disorders. Although SLC52A3 and SLC52A2 that encode riboflavin transporters are their only known causative genes, many patients without mutations in these genes have been reported. Clinical a...
Main Authors: | Marzieh Khani, Hosein Shamshiri, Shahriar Nafissi, Najmeh Salehi, Hamidreza Moazzeni, Hanieh Taheri, Elahe Elahi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.8394 |
Similar Items
-
A case report of riboflavin transporter deficiency: A novel heterozygous pathogenic variant in the SLC52A3 gene
by: Elizabeth S. Tranel, et al.
Published: (2024-03-01) -
First report of paternal uniparental disomy of chromosome 8 with SLC52A2 mutation in Brown-vialetto-van laere syndrome type 2 and an analysis of genotype-phenotype correlations
by: Siyu Zhao, et al.
Published: (2022-09-01) -
Riboflavin in Brown-Vialetto-Van Laere Syndrome
by: J Gordon Millichap, et al.
Published: (2014-03-01) -
A riboflavin-responsive neuronopathy with unique characteristics: Brown-Vialetto- Van Laere syndrome
by: Soreya BELARBI, et al.
Published: (2022-06-01) -
A riboflavin-responsive neuronopathy with unique characteristics: Brown-Vialetto- Van Laere syndrome
by: Soreya BELARBI, et al.
Published: (2022-06-01)